✦ LIBER ✦

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

✍ Scribed by M. Reni; S. Cereda; E. Bonetto; M. G. Viganò; P. Passoni; A. Zerbi; G. Balzano; R. Nicoletti; C. Staudacher; V. Di Carlo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

792 PUBLICATION Preliminary results of a

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB

The cisplatin, epirubicin, 5-fluorouraci

✍ Stefano Cereda; Paolo Passoni; Michele Reni; Maria G. Viganò; Luca Aldrighetti; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

PEFG (cisplatin, epirubicin, 5-fluoroura

✍ M. Reni; S. Cereda; L. Galli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 99 KB

6599 Adjuvant PEFG (cisplatin, epirubici

✍ Reni, M.; Cereda, S.; Aprile, G.; Tronconi, M.C.; Milandri, C.; Passoni, P.; Rog 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Adjuvant PEFG (Cisplatin, Epirubicin, 5-

✍ Reni, Michele; Balzano, Gianpaolo; Aprile, Giuseppe; Cereda, Stefano; Passoni, P 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 315 KB

Gemcitabine versus cisplatin, epirubicin

✍ Michele Reni; Stefano Cordio; Carlo Milandri; Paolo Passoni; Elisa Bonetto; Cris 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 105 KB